[HTML][HTML] Policy alternatives for treatments for rare diseases
AH Panju, CM Bell - CMAJ, 2010 - Can Med Assoc
Diseases have varying levels of prevalence in different regions. Hepatocellular carcinoma,
for instance, is highly prevalent in China (incidence of 95.7/100 000 people) but is relatively …
for instance, is highly prevalent in China (incidence of 95.7/100 000 people) but is relatively …
Investigation of oxidative stress in blood, brain, kidney, and liver after oxime antidote HI-6 application in a mouse experimental model
M Pohanka, J Sobotka, H Svobodova… - Drug and Chemical …, 2011 - Taylor & Francis
Oxime reactivator HI-6 (asoxime, in some sources) is a potent antidote suitable for treatment
of intoxication by nerve agents. Despite the fact that HI-6 is considered for practical …
of intoxication by nerve agents. Despite the fact that HI-6 is considered for practical …
Neglecting the Essentials: Addressing Barriers to Accessing Off-Patent Essential Medicines for Neglected Diseases in Canada
AR Houston - 2022 - ruor.uottawa.ca
In Canada, less than half of the drugs that the World Health Organization classifies as
Essential Medicines for the treatment of Neglected Diseases like Chagas disease, drug …
Essential Medicines for the treatment of Neglected Diseases like Chagas disease, drug …
The introduction of new drugs into anaesthetic practice: a perspective in pharmaceutical development and regulation
I Gilron - Canadian journal of anaesthesia, 1995 - Springer
This article reviews the process by which new drugs are introduced into anaesthetic practice
with particular emphasis on pharmaceutical development and government regulation. After …
with particular emphasis on pharmaceutical development and government regulation. After …
[BOOK][B] Qualitative evaluation of the Canadian Fabry Disease Initiative using key informant interviews.
M Embrett - 2011 - library-archives.canada.ca
Abstract<? Pub Inc> The objectives of this study were to evaluate the Canadian Fabry
Disease Initiative (CFDI) using input from key informants. A qualitative strategy composed of …
Disease Initiative (CFDI) using input from key informants. A qualitative strategy composed of …
[HTML][HTML] Utilisation du programme d'accès spécial de Santé Canada par les pharmaciens du Québec et comparaison avec d'autres pays
JF Bussières, S Atkinson, A Blanc, D Lebel… - Canadian Journal of …, 2005 - cjhp-online.ca
Objectif: Décrire l'utilisation du programme d'accès spécial (PAS) de Santé Canada par les
pharmaciens d'établissements du Québec en 2001-2002. Méthode: Il s' agit d'un sondage …
pharmaciens d'établissements du Québec en 2001-2002. Méthode: Il s' agit d'un sondage …